CCN2 and breast cancer: Together, our study emphasises the differentiation and anti-tumorigenic role of PRL in breast cancer by blocking the YAP-CCN2 oncogenic pathway providing prognostic and therapeutic strategies in breast cancer with also potential impact in other cancer types.